youtube_live
Q1 2026 earnings • 5:00 PM today
See detailschevron_right
EXEL:NASDAQ
Exelixis Inc
၄၄.၁၇ US$
arrow_upward
+၁.၁၂%(+၀.၄၉) 1D
၄၄.၁၇ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: မေ ၄, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EXEL...
Open
၄၃.၅၁ US$
High
၄၄.၃၂ US$
Low
၄၃.၅၀ US$
Mkt. cap
ဋေ ၁.၁၂ ထ
Avg. vol.
၂.၄၅ သန်း
Volume
၂၂.၀၀
P/E ratio
၁၅.၉၁
52-wk high
၄၉.၄၀ US$
52-wk low
၃၃.၇၆ US$
EPS
၂.၇၈ US$
Beta
၀.၃၈
Shares outstanding
၂၅.၄၀ ကုဋေ
No. of employees
၁ ထောင်
News stories
From sources across the web
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ ရက်
Assessing Exelixis (EXEL) Valuation After Mixed Share Performance And CABOMETYX Growth Narrative
Profile
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
About Exelixis Inc
CEOMichael M. Morrissey
Employees၁.၀၈ ထောင်
Founded၁၉၉၄ နို ၁၅
HeadquartersAlameda, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteexelixis.com
AI content may include mistakes. Learn more